Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOMDF · Entity 6884 | Director | November 17, 2025 | November 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2035-11-16 | Direct | 1,823,107 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 1,823,107 · Balance 1,823,107 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2025 Filed Nov 18, 2025 16:45 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantStock Appreciation Right · Derivative | 1,823,107 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001654954-25-013225 · section16.xml · derivative · entry 1 Cohen Robert · CIK 0001815574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,823,107 Underlying: Common · 1,823,107 shares Expires 2035-11-16 Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 16:09 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Appreciation Rights · Derivative | 1,823,107 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001654954-24-014267 · section16.xml · derivative · entry 1 Cohen Robert · CIK 0001815574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,823,107 Underlying: Common · 1,823,107 shares Expires 2034-11-10 Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 19:12 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 1,465,727 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001654954-22-016449 · section16.xml · derivative · entry 1 Cohen Robert · CIK 0001815574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,465,727 Underlying: Common Stock · 1,465,727 shares Expires 2032-12-09 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on December 9, 2023. Read SEC document |
| June 30, 2021 Filed Jun 30, 2021 16:50 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock option (right to buy) · Derivative | 543,750 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001171843-21-004627 · ownership.xml · derivative · entry 3 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,262,500 Underlying: Common Stock, without par value · 543,750 shares Expires 2030-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021. Read SEC document |
| June 30, 2021 Filed Jun 30, 2021 16:50 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 543,750 | $0.82 | $447,343.13 |
DisclosureSEC source: 0001171843-21-004627 · ownership.xml · nonDerivative · entry 2 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.815 to $0.845 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 30, 2021 Filed Jun 30, 2021 16:50 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 543,750 | $0.23 | $125,062.50 |
DisclosureSEC source: 0001171843-21-004627 · ownership.xml · nonDerivative · entry 1 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 1, 2021 16:43 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock option (right to buy) · Derivative | 1,193,750 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001171843-21-003938 · ownership.xml · derivative · entry 5 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,806,250 Underlying: Common Stock, without par value · 1,193,750 shares Expires 2030-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021. Read SEC document |
| June 01, 2021 Filed Jun 1, 2021 16:43 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock option (right to buy) · Derivative | 2,000,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-21-003938 · ownership.xml · derivative · entry 4 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, without par value · 2,000,000 shares Expires 2025-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options fully vested. Read SEC document |
| June 01, 2021 Filed Jun 1, 2021 16:43 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 3,193,750 | $0.81 | $2,595,880.00 |
DisclosureSEC source: 0001171843-21-003938 · ownership.xml · nonDerivative · entry 3 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.8499 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 01, 2021 Filed Jun 1, 2021 16:43 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 1,193,750 | $0.23 | $274,562.50 |
DisclosureSEC source: 0001171843-21-003938 · ownership.xml · nonDerivative · entry 2 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,193,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 1, 2021 16:43 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 2,000,000 | $0.19 | $380,000.00 |
DisclosureSEC source: 0001171843-21-003938 · ownership.xml · nonDerivative · entry 1 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 16:06 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 12,000,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001171843-21-000079 · ownership.xml · derivative · entry 1 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000,000 Underlying: Common Shares, without par value · 12,000,000 shares Expires 2030-12-30 F1 · derivative.exercise_date: The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 16:06 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 12,000,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001171843-21-000024 · ownership.xml · derivative · entry 1 Cohen Robert · CIK 0001815574 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000,000 Underlying: Common Shares, without par value · 12,000,000 shares Expires 2030-12-30 F1 · derivative.exercise_date: The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 17:04 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 2,000,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0000905718-20-000599 · zomedica_fm4jun162020.xml · derivative · entry 1 Cohen Robert · CIK 0001815574 · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Shares, without par value · 2,000,000 shares Expires 2025-06-16 F1 · derivative.exercise_date: Options to purchase 666,667 shares vest June 16, 2020, with the remaining options to vest, if at all, upon the achievement of certain performance targets and continued employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.